Iron Sucrose Injection — FDA Drug Shortage

To Be Discontinued — Mylan Institutional, A Viatris Company

The FDA lists a drug shortage record for Iron Sucrose Injection (injection) from Mylan Institutional, A Viatris Company with status To Be Discontinued. The shortage was first posted on May 21, 2026.

Shortage details

Status
To Be Discontinued
Company
Mylan Institutional, A Viatris Company
Package NDC
67457-957-99
Dosage Form
Injection
Presentation
Iron Sucrose, Injection, 50 mg/2.5 mL (NDC 67457-957-99)
Initial Posting
May 21, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.